Simplex Trading’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,571
| Closed | – | – | 10132 |
|
|
2025
Q3 | $0 | Sell |
2,571
-300
| -10% | -$86 | ﹤0.01% | 10118 |
|
|
2025
Q2 | $1K | Sell |
2,871
-28,037
| -91% | -$24K | ﹤0.01% | 8448 |
|
|
2025
Q1 | $32K | Buy |
+30,908
| New | +$55.8K | ﹤0.01% | 6201 |
|
|
2024
Q3 | – | Sell |
-1,187
| Closed | -$1.74K | – | 9636 |
|
|
2024
Q2 | $1K | Sell |
1,187
-427
| -26% | -$648 | ﹤0.01% | 8583 |
|
|
2024
Q1 | $2K | Sell |
1,614
-699
| -30% | -$1.21K | ﹤0.01% | 8472 |
|
|
2023
Q4 | $4K | Buy |
+2,313
| New | +$4.3K | ﹤0.01% | 8020 |
|
|
2023
Q2 | – | Sell |
-4,517
| Closed | -$11.9K | – | 9984 |
|
|
2023
Q1 | $7K | Buy |
+4,517
| New | +$18.1K | ﹤0.01% | 7852 |
|
|
2022
Q4 | – | Sell |
-2,997
| Closed | -$8.71K | – | 10479 |
|
|
2022
Q3 | $11K | Buy |
2,997
+2,022
| +207% | +$12.8K | ﹤0.01% | 8176 |
|
|
2022
Q2 | $5K | Sell |
975
-996
| -51% | -$8.31K | ﹤0.01% | 8870 |
|
|
2022
Q1 | $22K | Sell |
1,971
-7,164
| -78% | -$80.4K | ﹤0.01% | 8163 |
|
|
2021
Q4 | $133K | Buy |
+9,135
| New | +$200K | ﹤0.01% | 5793 |
|
|
2021
Q1 | – | Sell |
-279
| Closed | -$19K | – | 10080 |
|
|
2020
Q4 | $0 | Buy |
+279
| New | +$13.5K | ﹤0.01% | 9117 |
|
|
2020
Q2 | – | Sell |
-18
| Closed | -$1.33K | – | 8396 |
|
|
2020
Q1 | $1K | Sell |
18
-6
| -25% | -$378 | ﹤0.01% | 7416 |
|
|
2019
Q4 | $1K | Buy |
+24
| New | +$1.69K | ﹤0.01% | 7135 |
|
|
2019
Q2 | – | Sell |
-11
| Closed | -$936 | – | 7820 |
|
|
2019
Q1 | $0 | Buy |
+11
| New | +$1.25K | ﹤0.01% | 7888 |
|
Simplex Trading's UBX Position: Q4 2025 in Review
Simplex Trading sold out of Unity Biotechnology (UBX) in Q4 2025, closing a stake of 2,571 shares.
Simplex Trading first reported a position in UBX in Q1 2019 and held it in 15 quarters. The position peaked at $133K in Q4 2021. 0 funds tracked by Wall St. Rank hold UBX as of Q4 2025.
- Simplex Trading reported no remaining Unity Biotechnology position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 2,571 Unity Biotechnology shares in Q4 2025.
- Simplex Trading first reported a position in Unity Biotechnology in Q1 2019 and held it in 15 quarters.
- Simplex Trading's Unity Biotechnology position peaked at $133K in Q4 2021.
- 0 funds tracked by Wall St. Rank held Unity Biotechnology as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.